113 related articles for article (PubMed ID: 33051058)
1. Cell fate decisions by c-Myc depend on ZBTB5 and p53.
Choi SH; Koh DI; Ahn H; Kim JY; Kim Y; Hur MW
Biochem Biophys Res Commun; 2020 Dec; 533(4):1247-1254. PubMed ID: 33051058
[TBL] [Abstract][Full Text] [Related]
2. A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.
Koh DI; Choi WI; Jeon BN; Lee CE; Yun CO; Hur MW
J Biol Chem; 2009 Jul; 284(30):19856-66. PubMed ID: 19491398
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.
Kim MK; Jeon BN; Koh DI; Kim KS; Park SY; Yun CO; Hur MW
J Biol Chem; 2013 Mar; 288(10):7053-64. PubMed ID: 23329847
[TBL] [Abstract][Full Text] [Related]
4. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
Ho JS; Ma W; Mao DY; Benchimol S
Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
[TBL] [Abstract][Full Text] [Related]
5. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription.
Faiola F; Liu X; Lo S; Pan S; Zhang K; Lymar E; Farina A; Martinez E
Mol Cell Biol; 2005 Dec; 25(23):10220-34. PubMed ID: 16287840
[TBL] [Abstract][Full Text] [Related]
6. Role of promyelocytic leukemia zinc finger (PLZF) in cell proliferation and cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) gene repression.
Choi WI; Kim MY; Jeon BN; Koh DI; Yun CO; Li Y; Lee CE; Oh J; Kim K; Hur MW
J Biol Chem; 2014 Jul; 289(27):18625-40. PubMed ID: 24821727
[TBL] [Abstract][Full Text] [Related]
7. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
8. TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells.
Lynch JT; Somerville TD; Spencer GJ; Huang X; Somervaille TC
Cell Death Dis; 2013 Apr; 4(4):e573. PubMed ID: 23559008
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells.
Nakajima W; Miyazaki K; Asano Y; Kubota S; Tanaka N
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918002
[TBL] [Abstract][Full Text] [Related]
10. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP.
Vervoorts J; Lüscher-Firzlaff JM; Rottmann S; Lilischkis R; Walsemann G; Dohmann K; Austen M; Lüscher B
EMBO Rep; 2003 May; 4(5):484-90. PubMed ID: 12776737
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
13. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
14. A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A.
Liu Q; Basu S; Qiu Y; Tang F; Dong F
Oncogene; 2010 May; 29(19):2843-52. PubMed ID: 20190815
[TBL] [Abstract][Full Text] [Related]
15. The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.
Lee KM; Choi WI; Koh DI; Kim YJ; Jeon BN; Yoon JH; Lee CE; Kim SH; Oh J; Hur MW
Oncogene; 2012 Mar; 31(11):1442-58. PubMed ID: 21804610
[TBL] [Abstract][Full Text] [Related]
16. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.
Tang Y; Luo J; Zhang W; Gu W
Mol Cell; 2006 Dec; 24(6):827-39. PubMed ID: 17189186
[TBL] [Abstract][Full Text] [Related]
17. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
Park S; Hahm ER; Lee DK; Yang CH
J Cell Biochem; 2004 Apr; 91(5):973-86. PubMed ID: 15034932
[TBL] [Abstract][Full Text] [Related]
19. Six lysine residues on c-Myc are direct substrates for acetylation by p300.
Zhang K; Faiola F; Martinez E
Biochem Biophys Res Commun; 2005 Oct; 336(1):274-80. PubMed ID: 16126174
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
